Description
Programme
Article: Programme
€2.42
Related products
-
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart -
1 year access Online Belgian Journal of Hematology (BJH)
€43.60 Add to cart -
Article: Highlights in gynaecological cancers
€2.42 Add to cart
